This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Buck Institute for Research on Aging, Napa Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 51 
1 out of 1 Years Active: 2025
Title: Jotham W Coe: Innovator in CD38 Inhibition
Introduction
Jotham W Coe is a notable inventor based in Niantic, Connecticut. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for CD38. His work is crucial in the treatment of various diseases and disorders.
Latest Patents
Jotham W Coe holds a patent for "Heteroaryl amide inhibitors of CD38." This patent discloses heteroaryl amide inhibitors of CD38 and outlines methods for making and using these compounds in the treatment of diseases and disorders. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Jotham has worked with reputable organizations such as Napa Therapeutics Limited and the Buck Institute for Research on Aging. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jotham has collaborated with notable individuals, including Robert A Volkmann and Eric M Verdin. These partnerships have enhanced his research and development efforts, leading to advancements in therapeutic solutions.
Conclusion
Jotham W Coe's work in developing CD38 inhibitors represents a significant advancement in medical science. His innovative contributions and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile